C. Mytilineou

发表

Levodopa in the treatment of Parkinson's disease: Current controversies

M. Hallett, Y. Agid, W. Poewe, 2004, Movement disorders : official journal of the Movement Disorder Society.

Deprenyl Protects Dopamine Neurons from the Neurotoxic Effect of 1‐Methyl‐4‐Phenylpyridinium Ion

C. Mytilineou, G. Cohen, 1985, Journal of neurochemistry.

Mesencephalic Dopamine Neurons Become Less Sensitive to 1 ‐Methyl‐4‐Phenyl‐l,2,3,6‐Tetrahydropyridine Toxicity During Development In Vitro

P. Danias, W. Nicklas, C. Mytilineou, 1989, Journal of neurochemistry.

Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP+-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF

C. Mytilineou, T. H. Park, 1992, Brain Research.

Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.

C. Mytilineou, R. Heikkila, F. Cabbat, 1977, European journal of pharmacology.

Impaired oxidation of pyruvate in human embryonic fibroblasts after exposure to L-dopa.

M. Yahr, P. Werner, C. Mytilineou, 1994, European journal of pharmacology.

Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease

M. Yahr, P. Werner, C. Mytilineou, 1994, Journal of neural transmission. Parkinson's disease and dementia section.

Epidermal growth factor-induced survival and proliferation of neuronal precursor cells from embryonic rat mesencephalon

C. Mytilineou, T. H. Park, J. Shen, 1992, Neuroscience Letters.

Glial Cells Mediate Toxicity in Glutathione‐Depleted Mesencephalic Cultures

C. Olanow, C. Mytilineou, B. Kramer, 1999, Journal of neurochemistry.

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon.

C. Mytilineou, G. Cohen, 1984, Science.

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

M. Yahr, C. Mytilineou, G. Cohen, 1984, European journal of pharmacology.

1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture

C. Mytilineou, G. Cohen, R. Heikkila, 1985, Neuroscience Letters.

l‐DOPA Up‐Regulates Glutathione and Protects Mesencephalic Cultures Against Oxidative Stress

S. K. Han, C. Mytilineou, G. Cohen, 1996, Journal of neurochemistry.

Ascorbic Acid in Mesencephalic Cultures: Effects on Dopaminergic Neuron Development

C. Mytilineou, H. Kalir, 1991, Journal of neurochemistry.

EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

D. Casper, C. Mytilineou, M. Blum, 1991, Journal of neuroscience research.

Basic Fibroblast Growth Factor Stimulation of Glial Cells Protects Dopamine Neurons from 6‐Hydroxydopamine Toxicity: Involvement of the Glutathione System

C. Mytilineou, G. Cohen, J. G. Hou, 1997, Journal of neurochemistry.

Tetrahydroisoquinoline alkaloids: uptake and release by adrenergic nerves in vivo.

C. Mytilineou, G. Cohen, R. Barrett, 1974, European journal of pharmacology.

Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.

C. Mytilineou, G. Cohen, R. Heikkila, 1976, The Journal of pharmacology and experimental therapeutics.

1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.

J. Bloomquist, C. Mytilineou, K. Castagnoli, 1994, The Journal of pharmacology and experimental therapeutics.

Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

C. Mytilineou, B. Kramer, Abraham D Goldman, 1999, Brain Research.

Studies on the Toxicity of MPTP to Dopamine Neurons in Tissue and Cell Cultures

P. Danias, C. Mytilineou, L. Friedman, 1988 .

The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations

C. Mytilineou, L. Friedman, 1987, Neuroscience Letters.

Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains

M. Yahr, C. Mytilineou, M. Panayotacopoulou, 1991, Journal of neural transmission. Parkinson's disease and dementia section.

Where isl-DOPA decar☐ylated in the striatum after 6-hydroxydopamine nigrotomy?

R. Duvoisin, C. Mytilineou, 1978, Brain Research.

Current status of selegiline as a neuroprotective agent in Parkinson's disease.

W. Tatton, C. Olanow, C. Mytilineou, 1998, Movement disorders : official journal of the Movement Disorder Society.

Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro

C. Mytilineou, J. G. Hou, Jyh‐Gong Gabriel Hou, 1996, Brain Research.

Lipopolysaccharide prevents cell death caused by glutathione depletion: possible mechanisms of protection

C. Olanow, J. Yabut, C. Mytilineou, 2002, Neuroscience.

Actin‐Stimulated Myosin Mg2+‐ATPase Inhibition by Brain Protein

C. Mytilineou, S. Berl, M. Chou, 1983, Journal of neurochemistry.

Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain.

M. Yahr, W. Whetsell, C. Mytilineou, 1978, Archives of neurology.

Regeneration of sympathetic neurons: Effect of decentralization

I. Black, C. Mytilineou, 1976, Brain Research.

Studies on the Metabolism and Toxicity of l‐Methyl‐4‐Phenyl‐l,2,3,6‐Tetrahydropyridine in Cultures of Embryonic Rat Mesencephalon

C. Mytilineou, L. Friedman, L. Friedman, 1988, Journal of neurochemistry.

5-Hydroxydopamine 'tagged' neuronal boutons in rabbit neostriatum: interrelationship between vesicles and axonal membrane.

V. Tennyson, C. Mytilineou, V M Tennyson, 1974, Brain research.

The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptake.

V. Tennyson, C. Mytilineou, G. Cohen, 1972, Brain research.

Target organ regulation of sympathetic neuron development

I. Black, M. Dibner, C. Mytilineou, 1977, Brain Research.

Development of adrenergic nerve terminals: The effects of decentralization

I. Black, C. Mytilineou, 1978, Brain Research.

Prevention of 6-hydroxydopamine neurotoxicity.

C. Mytilineou, G. Cohen, R. Heikkila, 1975, European journal of pharmacology.

Glutathione depletion and oxidative stress.

J. Yabut, C. Mytilineou, Catherine Mytilineou, 2002, Parkinsonism & related disorders.

Toxic and Protective Effects of l‐DOPA on Mesencephalic Cell Cultures

C. Mytilineou, G. Cohen, Shan‐Kuo Han, 1993, Journal of neurochemistry.

6,7-Dihydroxytetrahydroisoquinoline: electron microscopic evidence for uptake into the amine-binding vesicles in sympathetic nerves of rat iris and pineal gland.

V. Tennyson, C. Mytilineou, G. Cohen, 1973, Brain research.

6,7-Dihydroxytetrahydroisoquinoline: Uptake and Storage by Peripheral Sympathetic Nerve of the Rat

C. Mytilineou, G. Cohen, R. Barrett, 1972, Science.

Trans-synaptic regulation of the development of end organ innervation by sympathetic neurons

I. Black, C. Mytilineou, 1976, Brain Research.

THE BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF 6‐AMINODOPAMINE: SIMILARITY WITH 6‐HYDROXYDOPAMINE

C. Mytilineou, G. Cohen, R. Heikkila, 1973, Journal of neurochemistry.

EVIDENCE FOR DEGENERATION OF SYMPATHETIC NERVE TERMINALS CAUSED BY THE ORTHO‐ AND PARA‐QUINONES OF 6‐HYDROXYDOPAMINE

C. Mytilineou, G. Cohen, R. Heikkila, 1973, Journal of neurochemistry.

Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.

C. Mytilineou, G. Cohen, R. Heikkila, 1975, The Journal of pharmacology and experimental therapeutics.

Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro

C. Mytilineou, C Mytilineou, MM Bouvier, 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions

C. Mytilineou, B. Kramer, 2004, Journal of neurocytology.

Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

C. Olanow, P. Shashidharan, K. McNaught, 2002, Journal of neurochemistry.

The Alzheimer Amyloid Precursor Proteoglycan (Appican) Is Present in Brain and Is Produced by Astrocytes but Not by Neurons in Primary Neural Cultures (*)

J. Shioi, N. Robakis, M. Pangalos, 1995, The Journal of Biological Chemistry.

Neurotransmitter analysis of dermal neurofibromas

A. Rubenstein, C. Mytilineou, J. Pearson, 1981, Neurology.

Human transplacental transfer of carbidopa/levodopa

M. Yahr, C. Mytilineou, D. Moros, 1995, Journal of neural transmission. Parkinson's disease and dementia section.

Peripheral catecholamine depletion in amyloid autonomic neuropathy.

M. Yahr, A. Rubenstein, C. Mytilineou, 1978, The Mount Sinai journal of medicine, New York.

Glial Cell Line‐Derived Neurotrophic Factor Exerts Neurotrophic Effects on Dopaminergic Neurons In Vitro and Promotes Their Survival and Regrowth After Damage by 1‐Methyl‐4‐Phenylpyridinium

C. Mytilineou, Leu-Fen H. Lin, Jyh‐Gong Gabriel Hou, 1996, Journal of neurochemistry.

Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.

C. Olanow, P. Werner, C. Mytilineou, 1998, The Journal of pharmacology and experimental therapeutics.

Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease.

C. Mytilineou, E. Leonardi, 1998, Advances in experimental medicine and biology.

Glial-Neuronal Interactions during Oxidative Stress Implications for Parkinson’s Disease

C. Mytilineou, 2013 .

Glial-Neuronal Interactions during Oxidative Stress

C. Mytilineou, 2002 .

Histochemical evaluation of glutathione in brain

A. Slivka, C. Mytilineou, G. Cohen, 1987, Brain Research.

Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress

C. Olanow, P. Shashidharan, K. McNaught, 2004, Journal of Neural Transmission.

l‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [l‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from Excitotoxicity In Vitro

C. Olanow, C. Mytilineou, P. Radcliffe, 1997, Journal of neurochemistry.

l‐Deprenyl Protects Mesencephalic Dopamine Neurons from Glutamate Receptor‐Mediated Toxicity In Vitro

C. Olanow, P. Werner, C. Mytilineou, 1997, Journal of neurochemistry.

The development of the dog nigrostriatal system in organotypic culture

M. Yahr, W. Whetsell, C. Mytilineou, 2005, Journal of Neural Transmission.

HISTOCHEMICAL REACTIONS OF HUMAN AUTONOMICGANGLIA.

C. Mytilineou, W. Shanklin, M. Issidorides, 1963, Journal of anatomy.

Fluorescence and electron microscopic studies of the early development of the substantia nigra and area ventralis tegmenti in the fetal rabbit

V. Tennyson, C. Mytilineou, R. Barrett, 1973, The Journal of comparative neurology.

Dopamine-containing neurons of the substantia nigra and their terminals in the neostriatum.

V. Tennyson, C. Mytilineou, P. Duffy, 1975, UCLA forum in medical sciences.

Correlation of anatomical and biochemical development of the rabbit neostriatum.

V. Tennyson, C. Mytilineou, G. Cohen, 1973, Progress in brain research.

Toxicity of glutathione depletion in mesencephalic cultures: a role for arachidonic acid and its lipoxygenase metabolites

C. Olanow, J. Yabut, C. Mytilineou, 2004, The European journal of neuroscience.

Decentralization of the superior cervical ganglion in neonates impairs the development of the innervation of the iris. A quantitative ultrastructural study

I. Black, G. Raisman, C. Mytilineou, 1979, Brain Research.

Histochemical alterations of sympathetic ganglia of the rat after reserpine administation.

C. Mytilineou, 1969, Biological Psychiatry.

Modifications of female sex chromatin (Barr body) in rat neurons after reserpine administration

C. Mytilineou, M. Issidorides, A. Beis, 2005, Experientia.

Levodopa Is Toxic to Dopamine Neurons in an in Vitro but Not an in Vivo Model of Oxidative Stress

C. Olanow, R. Walker, C. Mytilineou, 2003, Journal of Pharmacology and Experimental Therapeutics.

Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

C. Mytilineou, G. Cohen, 1985, Life sciences.

The interaction of nerve growth factor and trans-synaptic regulation in the development of target organ innervation by sympathetic neurons

I. Black, C. Mytilineou, 1976, Brain Research.

6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteine.

P. Danias, C. Mytilineou, 1989, Biochemical pharmacology.

Pharmacodynamic properties of catecholamine-derived TIQ's and 7-O-methylated metabolites in neuronal systems.

C. Mytilineou, G. Cohen, 1982, Progress in clinical and biological research.